# Umbilical Cord Blood vs Personalized Treatments for Improving Autistic Disorder

> **NCT04007224** · PHASE1 · COMPLETED · sponsor: **Fundatia Bio-Forum** · enrollment: 35 (actual)

## Conditions studied

- Autistic Spectrum Disorder

## Interventions

- **DRUG:** Intranasal oxytocin
- **BIOLOGICAL:** Autologous umbilical cord blood

## Key facts

- **NCT ID:** NCT04007224
- **Lead sponsor:** Fundatia Bio-Forum
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-17
- **Primary completion:** 2023-06-28
- **Final completion:** 2023-07-10
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2023-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04007224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04007224, "Umbilical Cord Blood vs Personalized Treatments for Improving Autistic Disorder". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04007224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*